EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Perineal wound complications after total neoadjuvant therapy or chemoradiotherapy followed by abdominoperineal excision in patients with high-risk locally advanced rectal cancer in the RAPIDO trial

Wouter H Zwart iD, Esmée A Dijkstra, Geke A P Hospers, Corrie A M Marijnen, Hein Putter iD, Joakim Folkesson, Cornelis J H Van de Velde, Annet G H Roodvoets, Elma Meershoek-Klein Kranenbarg, Bengt Glimelius, Boudewijn Van Etten, Per J Nilsson

BJS Open · 2025

DOI: 10.1093/bjsopen/zraf043 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift BJS Open, 2025. Verfasst von Wouter H Zwart und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, University Medical Centre Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Chemoradiotherapy, Neoadjuvant Therapy, Perineum, Postoperative Complications. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Dutch Cancer Foundation, Swedish Cancer Society, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Perineal wound complications (PWCs) occur in 15–30% of patients after abdominoperineal excision (APE) and are associated with adverse events, such as delayed wound healing, prolonged hospitalization, a delay in initiating postoperative chemotherapy, and decreased quality of life. Preoperative radiotherapy and chemotherapy are risk factors for wound complications. It is unknown whether total neoadjuvant treatment (TNT) affects the risk of PWCs compared with chemoradiotherapy (CRT).

Methods

This study compared patients from the experimental (EXP; short-course radiotherapy, chemotherapy, and surgery as TNT) and standard-of-care (STD; CRT, surgery, and postoperative chemotherapy depending on hospital policy) treatment arms of the RAPIDO trial who underwent APE within 6 months after preoperative treatment. The primary outcome was the incidence of PWCs (infection, abscess, dehiscence, wound discharge, presacral abscess affecting the perineum) of any grade ≤ 30 days after APE. Secondary outcomes were the incidence of PWCs >30 days after APE, length of hospital stay, characteristics associated with PWCs, and oncological outcomes in patients with versus without PWC.

Results

Of the 901 patients who started treatment (460 in EXP arm, 441 in STD arm), 153 (33%) and 160 (36%) underwent APE after TNT and CRT, respectively. After TNT and CRT, the incidence of PWCs ≤30 days after APE, readmission, and reoperation was 54 of 153 (35%) versus 53 of 160 (33%) (P = 0.69), 9% versus 12% (P = 0.54), and 7% versus 8% (P = 0.75), respectively. The median length of hospital stay was 2–3 days longer for patients with PWC. Univariable analysis revealed that pretreatment albumin <35 g/l, hypertension, and haemoglobin ≤ 8.0 mmol/l were associated with PWC. Oncological outcomes were similar between patients with and without PWCs.

Conclusion

In the RAPIDO trial, TNT and CRT resulted in a similar incidence of PWCs among patients with high-risk locally advanced rectal cancer who underwent APE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChemoradiotherapyNeoadjuvant TherapyPerineumPostoperative ComplicationsProctectomyRectal NeoplasmsAgedFemaleHumansMaleMiddle AgedIncidenceLength of StayRisk FactorsSurgical Wound DehiscenceSurgical Wound InfectionWound HealingClinical Trials, Phase III as TopicMulticenter Studies as TopicRandomized Controlled Trials as TopicSecondary Data Analysis

Autor:innen und Institutionen

  • Department of Medical Oncology, University Medical Centre Groningen, Groningen, the Netherlands.
  • Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Department of Radiation Oncology Sciences, Leiden University Medical Centre, Leiden, the Netherlands.
  • Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, the Netherlands.
  • Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands.

ORCID-Profile: Wouter H Zwart, Hein Putter

Förderung

  • Dutch Cancer Foundation
  • Swedish Cancer Society
  • Swedish Research Council
  • Spanish Ministry of Economy and Competitiveness
  • Carlos III Health Institute
  • Spanish Clinical Research Network
  • European Union's Horizon 2020
  • Marie Skłodowska-Curie

Zitieren

APA

Zwart, W. H., Dijkstra, E. A., Hospers, G. A. P., Marijnen, C. A. M., Putter, H., Folkesson, J., Van de Velde, C. J. H., Roodvoets, A. G. H., Meershoek-Klein Kranenbarg, E., Glimelius, B., Van Etten, B., & Nilsson, P. J. (2025). Perineal wound complications after total neoadjuvant therapy or chemoradiotherapy followed by abdominoperineal excision in patients with high-risk locally advanced rectal cancer in the RAPIDO trial. BJS Open. https://doi.org/10.1093/bjsopen/zraf043

Vancouver

Zwart WH, Dijkstra EA, Hospers GAP, Marijnen CAM, Putter H, Folkesson J, et al. Perineal wound complications after total neoadjuvant therapy or chemoradiotherapy followed by abdominoperineal excision in patients with high-risk locally advanced rectal cancer in the RAPIDO trial. BJS Open. 2025. doi:10.1093/bjsopen/zraf043

BibTeX
@article{Zwart2025,
  author = {Zwart, Wouter H and Dijkstra, Esmée A and Hospers, Geke A P and Marijnen, Corrie A M and Putter, Hein and Folkesson, Joakim and Van de Velde, Cornelis J H and Roodvoets, Annet G H and Meershoek-Klein Kranenbarg, Elma and Glimelius, Bengt and Van Etten, Boudewijn and Nilsson, Per J},
  title = {Perineal wound complications after total neoadjuvant therapy or chemoradiotherapy followed by abdominoperineal excision in patients with high-risk locally advanced rectal cancer in the RAPIDO trial},
  journal = {BJS Open},
  year = {2025},
  doi = {10.1093/bjsopen/zraf043}
}
Kostenlos starten →